Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Multigam IV (5% vs. 10%) in Patients With an Immunodeficiency Secondary to a Hematological Disorder

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Age =\> 18 years~* Immunodeficiency secondary to a hematologic disorder~* Patient has received at least 2 Multigam IV 5% administrations~* Patient may not have had any adverse events (grade 2 or higher according to CTCAE v4.03) during the last 2 Multigam IV 5% administrations~* Patient needs at least 2 more immunoglobulin administrations~* Signed informed consent~Exclusion Criteria:~* Patient has received less than 2 Multigam IV 5% administrations~* Patient has had an adverse event (grade 2 or higher according to CTCAE v4.03) during the last 2 Multigam IV 5% administrations~* Refusal to sign informed consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).